3-cyanopyridine has been researched along with Benign Neoplasms in 1 studies
pyridine-3-carbonitrile: structure in first source
3-pyridinecarbonitrile : A nitrile that is pyridine substituted by a cyano group at position 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| "3-Cyanopyridine is an excellent backbone for antitumor lead compounds, 10n and 9o, as derivatives of 3-Cyanopyridine are excellent survivin protein-targeting inhibitors worthy of further study." | 1.91 | Design, Synthesis, and Molecular Docking Study of Novel 3-Cyanopyridine Derivatives for the Anti-Cancer Drug Target Survivin Protein. ( Jiang, LH; Lai, WJ; Lei, FH; Lu, JH; Shen, LQ; Wu, AQ, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lu, JH | 1 |
| Lai, WJ | 1 |
| Jiang, LH | 1 |
| Lei, FH | 1 |
| Shen, LQ | 1 |
| Wu, AQ | 1 |
1 other study available for 3-cyanopyridine and Benign Neoplasms
| Article | Year |
|---|---|
Design, Synthesis, and Molecular Docking Study of Novel 3-Cyanopyridine Derivatives for the Anti-Cancer Drug Target Survivin Protein.
Topics: Amino Acids; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Design; Drug Screenin | 2023 |